Institute for Glycomics researchers awarded $1.1 million from NHMRC to develop new antibiotics for drug resistant gonorrhoea.

Researchers have received grants worth over $6.96 million from the Australian Research Council.

A Griffith study has found childhood COVID vaccination leads to high reductions in child disease and mortality, but is more beneficial to adults, particularly the unvaccinated.

Institute for Glycomics researchers receive funding boost in their fight against cancer with $2.6 million awarded by the Australian Cancer Research Foundation.

Griffith University researchers have secured more than $2.6M in NHMRC Ideas Grants.

Broad-spectrum malaria vaccine can be freeze-dried making it suitable for deployment into malaria-endemic countries.

Communicating a thesis on complex adaptive systems theory in just three minutes is no simple task, but Amy Kirkegaard did it in style to win the Griffith Three Minute Thesis (3MT) competition on Friday.

A trio of emerging Griffith University health scientists have been named as Queensland Young Tall Poppies for 2021.

The Institute for Glycomics 21st Birthday Grand Ball presented by Meriton Group will be held on Saturday 14 August at RACV Royal Pines Resort. The elegant black-tie affair featuring a special feature performance by one of Australia’s most successful comics Akmal Saleh, aims to raise funds for the Institute’s research into finding new drugs, vaccines […]

Griffith University’s Institute for Glycomics celebrates the promotion of six of its researchers, in recognition of their outstanding contributions to research. Associate Professor Kate Seib, Research Leader at the Institute for Glycomics, has been promoted to Professor. “I am very excited about this promotion, and so grateful to my team, my collaborators and my mentors […]

Griffith University researchers have developed a new vaccine in pre-clinical studies to treat human babesiosis, a tick-transmitted disease closely related to malaria.

Scientists have visualised and investigated a key molecular pathway that could one day help treat inflammation, diabetes, cancer, infectious diseases and potentially even COVID-19.

Some of Griffith University’s most outstanding research students have been acknowledged at the Institute for Glycomics Student Scholarships Awards evening. Awards from the following schemes were presented at the event: 2020/2021 Summer Scholarships 2021 Glycomics Student Scholarships 2020/2021 Summer Scholarships The 2020/2021 Summer Scholarships scheme is proudly supported by Community Bank of Paradise Point, Bendigo […]

For the entire month of May, and highlighting Mother’s Day, Griffith University’s Institute for Glycomics is partnering with local Gold Coast florists to raise funds and awareness to support vital research into cancers that affect women. “The Mum’s the Word Mother’s Day campaign invites the local community to ‘thank her a bunch’ by gifting the […]

A class of metal-based compounds acts as a shield to protect cells from viruses new research has found.

Repurposed medications may guide future strategies for COVID-19 treatment.

Using convalescent plasma, Griffith University researchers have identified how it may be possible to make a future vaccine that will provide protection against all major strains of COVID-19

A Griffith University-led research team has discovered how a therapeutic target common among debilitating neurodegenerative disorders is activated, which could help accelerate drug development.